TW200501942A - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
TW200501942A
TW200501942A TW093108729A TW93108729A TW200501942A TW 200501942 A TW200501942 A TW 200501942A TW 093108729 A TW093108729 A TW 093108729A TW 93108729 A TW93108729 A TW 93108729A TW 200501942 A TW200501942 A TW 200501942A
Authority
TW
Taiwan
Prior art keywords
pharmaceutical compositions
propylcarbamate
phosphonooxy
sulphonyl
aminophenyl
Prior art date
Application number
TW093108729A
Other languages
English (en)
Chinese (zh)
Inventor
Amyn Pyarali Sayani
Mehran Maleki
Kwok Yui Chow
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of TW200501942A publication Critical patent/TW200501942A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW093108729A 2003-04-01 2004-03-30 Pharmaceutical compositions TW200501942A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45929803P 2003-04-01 2003-04-01

Publications (1)

Publication Number Publication Date
TW200501942A true TW200501942A (en) 2005-01-16

Family

ID=33098296

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093108729A TW200501942A (en) 2003-04-01 2004-03-30 Pharmaceutical compositions

Country Status (3)

Country Link
CA (1) CA2425031A1 (fr)
TW (1) TW200501942A (fr)
WO (1) WO2004091280A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007070504A2 (fr) * 2005-12-13 2007-06-21 Morton Grove Pharmaceuticals, Inc. Compositions orales liquides de sumatriptan stables et de gout agreable

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6436989B1 (en) * 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
AU2002365234B2 (en) * 2001-12-14 2009-01-29 Pharmasset Inc N4-acylcytosine nucleosides for treatment of viral infections

Also Published As

Publication number Publication date
WO2004091280A2 (fr) 2004-10-28
WO2004091280A3 (fr) 2005-02-17
CA2425031A1 (fr) 2004-10-01

Similar Documents

Publication Publication Date Title
YU3401A (sh) Kalcijum (3s)tetrahidro-3-furanil(1s,2r)-3-(((4-aminofenil) sulfonil) (izobutil)amino)-1-benzil-2-(fosfonooksi) propilkarbamat
MX2009005462A (es) Analogos de 7,8-saturados-4,5-epoxi-morfinano.
TNSN08024A1 (en) 7-substituted aza-indazoles, compositions containing same, production method and use thereof
TW200508214A (en) Novel compounds
IL188475A0 (en) Pyrido [2,3-d]pyrimidine-2,4-diamine compounds as ptpib inhibitors
TW200505875A (en) Novel compounds
MX2007004276A (es) 1,5-naftiridin-azolidinonas que tienen actividad antiproliferativa de cdk-1.
MX2007005936A (es) Una sintesis asimetrica del acido (s)-(+)-3-(aminometil)-5- metilhexanoico.
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
TW200604149A (en) Norbornane based cycloaliphatic compounds containing nitrile groups
TW200501942A (en) Pharmaceutical compositions
MY142076A (en) Emulsifying systems containing azetidine derivatives
MX2007006018A (es) Suspension farmaceutica oral novedosa de cristal de cefdinir.
WO2001000635A3 (fr) Derives de (3s) tetrahydro-3-furanyl (1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-(phosphono-oxy)propylcarbamate
WO2005016371A8 (fr) Polypeptides de l'interferon-beta-1b humains recombinants ameliores
GB0221169D0 (en) Crystal
TW200505435A (en) Treatment of ocular disorders
MY142077A (en) Semi-solid systems containing azetidine derivatives
TW200610526A (en) Novel hydrophilic analogs of 4,8-dihydrobenzodithiophene-4,8-diones as anticancer agents
EP1809599B8 (fr) Analogues de la vitamine d<sb>3</sb>pour la prevention et pour le traitement de troubles osseux
WO2006023707A3 (fr) Utilisation de 2-aminothiophenecarboxamides comme agents chimiotherapeutiques dans le traitement du cancer
IL196605A0 (en) Processes for the preparation of n-(2-acetyl-4,6-dimethylphenyl)-3-{[3,4-dimethyl-5-isoxazolyl)amino]sulfonyl}-2-thiophenecarboxamide
TH56922C3 (th) แคลเซียม (3s) เททระไฮโดร-3-ฟิวแรนิล (1s,2r)-3-[[(4-อะมิโนฟีนิล)ซัลโฟนิล](ไอโซบิวทิล)อะมิโน]-1-เบนซิล-2-(ฟอสโฟโนออกซี)โพรพิลคาร์บาเมต
WO2003104260A3 (fr) Formulation pharmaceutique
WO2005019224A3 (fr) Nouveaux composes anti-infectieux